BridgeMD
New treatment option for Schizophrenia
Official title Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
ClinicalTrials.gov ID: NCT04871048
What this study is testing
- What it's testing
- Cannabis use disorder is a frequent comorbidity of schizophrenia, associated with increased symptoms and less adherence to therapy. Validated care has limited effectiveness in this population and development of new management strategies seems necessary.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Schizophrenia diagnostic according to DSM (Diagnostic and Statistical Manual of mental disorder) 5 criteria, without change in psychotropic treatment...
- Moderate to severe cannabis use disorder according to DSM 5 criteria and active consumption during the last 7 days
- people motivated to reduce or quit their cannabis consumption
- Patients with ambulatory compulsory care may be included
You likely can't join if
- Other substance use disorder, excluding nicotine, according to DSM 5 criteria
- Other current psychiatric disorder according to DSM 5 criteria, excluding personality disorder
- Inpatient hospitalization
- History of head injury, neurological disorder with cerebral consequence or severe unstable somatic disorder
- Pregnancy or no contraception
- Contraindications for tDCS and/or MRI (implanted material, uncontrolled epilepsy, intracranial hypertension)
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
- Clermont-Ferrand, France
- Dijon, France
- La Tronche, France
- Saint-Cyr-au-Mont-d'Or, France
- Saint-Égrève, France
- Saint-Priest-en-Jarez, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France; Clermont-Ferrand, France; Dijon, France; La Tronche, France; Saint-Cyr-au-Mont-d'Or, France; Saint-Égrève, France and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.